6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Pharmacotherapy for Cocaine Addiction
Cocaine addiction presents a significant challenge in treatment, as there are currently no FDA-approved medications specifically for its management. However, various pharmacotherapies are being explored to mitigate cravings and reduce relapse rates. Medications such as antidepressants, dopamine agonists, and anti-anxiety drugs can be used to treat the underlying neurochemical imbalances associated with cocaine addiction. Behavioral therapies, such as cognitive-behavioral therapy (CBT), are often integrated with pharmacological interventions to address the psychological components of addiction. Combining pharmacotherapy with psychosocial treatments has shown promise in improving long-term recovery outcomes for individuals with cocaine addiction.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Michelle Charbonnier
MoNetwork, United States
Monica Zuniga Fajuri
Tiburcio Vasquez Health Center, United StatesSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Gangstalking is real, should be studied
Sam Vaknin, Southern Federal University, United Kingdom
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Sensoria driven genetic decoupling and impaired areal integration in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Positive outcome of adherence to the reward deficiency syndrome solution system treatment plan: A longitudinal study
Elizabeth Dale Gilley, The Elle Foundation, United States